Kiora Pharmaceuticals Inc. buy BiotechBee
Start price
04.02.24
/
60%
€0.69
Target price
31.12.25
€1.00
Performance (%)
-37.75%
End price
14.12.24
-
Summary
This prediction is currently being closed. Massive losses of -37.75% have been the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Kiora Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | 0.336% | 4.366% | 21.868% |
| iShares Nasdaq 100 | 0.541% | 3.170% | 7.017% |
| iShares Nikkei 225® | 4.048% | 6.727% | 22.855% |
| iShares S&P 500 | 0.795% | 3.281% | 4.698% |
According to BiotechBee what are the pros and cons of Kiora Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Kiora Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 1,0
In the thread Trading Kiora Pharmaceuticals Inc.
Buy beendet

